NCT06171139 is a NA clinical trial of Counseling Tool in Prostate Cancer, sponsored by University of California, San Francisco.

Who is sponsoring NCT06171139?

NCT06171139 is sponsored by University of California, San Francisco.

What drugs are being tested in NCT06171139?

Interventions in NCT06171139: Counseling Tool, Questionnaires.

What condition does NCT06171139 study?

NCT06171139 studies Prostate Cancer, Prostate Cancer Metastatic.

Is NCT06171139 still recruiting?

NCT06171139 is currently recruiting now. Last updated 16 April 2026.

Last reviewed 2026-04-16 · How we verify

NCT06171139

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Recruiting now NA Last updated 16 April 2026

What this trial tests

NA trial testing Counseling Tool in Prostate Cancer in 80 participants. Currently enrolling.

Timeline

1 December 2023

Primary endpoint
31 May 2027

31 August 2027

Quick facts

Lead sponsor	University of California, San Francisco
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	80
Start date	1 December 2023
Primary completion	31 May 2027
Estimated completion	31 August 2027
Sites	1 location across United States

Drugs / interventions tested

Counseling Tool
Questionnaires

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →
Prostate Cancer Metastatic — all drugs for Prostate Cancer Metastatic →

Sponsor

University of California, San Francisco

Who can join

18 and older, male only, with Prostate Cancer or Prostate Cancer Metastatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of the study is to improve equitable delivery of pre-Tumor genetic testing (TGT) counseling tool for Black or African American men with metastatic prostate cancer and evaluating the tool for implementation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.
Kaushal JB, Raut P, Muniyan S, Siddiqui JA, et al · · 2024 · cited 4× · PMID 38902476 · DOI 10.1007/s10555-024-10193-8

Verify or expand the search:

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other University of California, San Francisco trials

Trials by the same sponsor.

NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06171139 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 16 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06171139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing